Onconova Therapeutics Inc., of Newtown, Pa., closed its previously announced offering of about 67.6 million shares of its common stock for 42.5 cents per share. The offering included warrants to purchase about 8.8 million 8.8 million shares of common stock and 220,588.225 shares of series B convertible preferred stock.